Abstract | OBJECTIVE: METHOD: Male SD rats were randomly divided into 5 groups according to the blood lipid values: normal group, hyperlipidemia group, 300 mg x kg(-1) x d(-1) Ber-treated group, 60 mg x kg(-1) x d(-1) Ber-treated group, and 7.2 mg x kg(-1) x d(-1) lovastatin-treated group. Normal group were fed with base diet and other groups were fed with high fat and cholesterol diet. 12 weeks after drugs were given the TC, TG, LDL-C, and HDL-C from rat blood samples were tested by automatic biochemistry analyzer. Gene expressions of CPT I A and PPARalpha were evaluated by RT-PCR and Western blot, respectively. RESULT: It was shown that Ber significantly decreased TC and LDL-C, but increased HDL-C in dose-dependent manner, elevated expressions of CPT I A mRNA and protein without influence on PPARalpha expression. Similar effects from lovastatin on lipidemia were observed except the Ber effect on CPT I A gene expression. CONCLUSION: Ber has modulating effect on the lipid metabolism, the mechanism of which may be by promoting the CPT I A gene expression.
|
Authors | Hong Wang, Lingyun Shi, Huafeng Yin, Qixin Zhou |
Journal | Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
(Zhongguo Zhong Yao Za Zhi)
Vol. 36
Issue 19
Pg. 2715-8
(Oct 2011)
ISSN: 1001-5302 [Print] China |
PMID | 22242436
(Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Drugs, Chinese Herbal
- PPAR gamma
- Berberine
- Carnitine O-Palmitoyltransferase
|
Topics |
- Animals
- Berberine
(administration & dosage)
- Carnitine O-Palmitoyltransferase
(genetics, metabolism)
- Disease Models, Animal
- Drugs, Chinese Herbal
(administration & dosage)
- Gene Expression
(drug effects)
- Humans
- Hyperlipidemias
(drug therapy, enzymology, genetics, metabolism)
- Lipid Metabolism
(drug effects)
- Male
- PPAR gamma
(genetics, metabolism)
- Random Allocation
- Rats
- Rats, Wistar
|